Antineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsRadiation InjuriesRadiation DosageRadiation, IonizingCell Line, TumorCombined Modality TherapyDose-Response Relationship, RadiationNeoplasmsRadiation ToleranceRadiotherapyBreast NeoplasmsDrug Screening Assays, AntitumorRadiotherapy DosageChemotherapy, AdjuvantCisplatinDoxorubicinApoptosisDrug Resistance, NeoplasmRadiationRadiation OncologyRadiation ProtectionTumor Cells, CulturedLung NeoplasmsCell SurvivalRadiotherapy, ConformalAntineoplastic Agents, PhytogenicMice, NudeTreatment OutcomeRadiotherapy, Intensity-ModulatedRadiation MonitoringRadiotherapy, AdjuvantCell ProliferationGene Expression Regulation, NeoplasticXenograft Model Antitumor AssaysDose FractionationPaclitaxelAntibiotics, AntineoplasticEtoposideColonic NeoplasmsNeoplasm StagingRadiation-Sensitizing AgentsRadiotherapy Planning, Computer-AssistedRadiation PneumonitisNeoplasm Recurrence, LocalSurvival AnalysisAdenocarcinomaDisease-Free SurvivalOvarian NeoplasmsNeoplasm MetastasisSurvival RateBrain NeoplasmsPrognosisNeoplasms, Radiation-InducedDrug Delivery SystemsBrachytherapyDose-Response Relationship, DrugProstatic NeoplasmsCarcinoma, Squamous CellTime FactorsCell CycleHead and Neck NeoplasmsGamma RaysCyclophosphamidePancreatic NeoplasmsRadiometryDNA DamageNeoplasm InvasivenessAntimetabolites, AntineoplasticCarcinoma, Non-Small-Cell LungCamptothecinNeoplasm ProteinsRadiation Injuries, ExperimentalNeoplasm TransplantationTumor BurdenRadiosurgeryFollow-Up StudiesDrug SynergismRNA, Small InterferingTumor Suppressor Protein p53Blotting, WesternCranial IrradiationDrug CarriersSignal TransductionFluorouracilVinblastineInhibitory Concentration 50CarcinomaStomach NeoplasmsCell DivisionCosmic RadiationOrganoplatinum CompoundsDrug Resistance, MultipleAntineoplastic Agents, AlkylatingDrug Administration ScheduleRNA, MessengerDeoxycytidineCarboplatinP-GlycoproteinBleomycin